# PYRIDOSTIGMINE BROMIDE
> **ANDA040502** · Abbreviated New Drug Application (Generic) · Sponsor: IMPAX LABS · Approved 2003-04-24
## Drug
- **FDA Application Number:** ANDA040502
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** PYRIDOSTIGMINE BROMIDE
- **Generic name:** PYRIDOSTIGMINE BROMIDE
- **Active ingredients:** PYRIDOSTIGMINE BROMIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** IMPAX LABS
- **Manufacturer:** Amneal Pharmaceuticals of New York LLC
- **First approval:** 2003-04-24
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=040502)
---
*AI Analytics · CC0 1.0*